1. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992; 257:1050–1056.
2. Martinez M, Silley P. Antimicrobial drug resistance. Handb Exp Pharmacol 2010; 199:227–264.
3. Morley P, Apley M, Besser T, et al. Antimicrobial drug use in veterinary medicine. J Vet Intern Med 2005; 19:617–629.
4. Ogeer-Gyles J, Mathews KA, Sears W, et al. Development of antimicrobial drug resistance in rectal Escherichia coli isolates from dogs hospitalized in an intensive care unit. J Am Vet Med Assoc 2006; 229:694–699.
5. Dunowska M, Morley PS, Traub-Dargatz JL, et al. Impact of hospitalization and antimicrobial drug administration on antimicrobial susceptibility patterns of commensal Escherichia coli isolated from the feces of horses. J Am Vet Med Assoc 2006; 228:1909–1917.
6. Samore MH, Magill MK, Alder SC, et al. from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 2001; 108:856–865.
7. Gustafsson I, Sjolund M, Torell E, et al. Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother 2003; 52:645–650.
8. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A 1999; 9:1152–1156.
9. Berge ACB, Atwill ER, Sischo WM. Animal and farm influences on the dynamics of antibiotic resistance in faecal Escherichia coli in young dairy calves. Prev Vet Med 2005; 69:25–38.
10. Platt TM, Loneragan GH, Scott HM, et al. Antimicrobial susceptibility of enteric bacteria recovered from feedlot cattle administered chlortetracycline in feed (Erratum published in Am J Vet Res 2008; 69:1163). Am J Vet Res 2008; 69:988–996.
11. Pena C, Albareda J, Pallares R, et al. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995; 3:520–524.
12. van den Bogaard AE, Stobberingh EE. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs 1999; 58:589–607.
13. Altekruse SF, Elvinger F, Lee KY, et al. Antimicrobial susceptibilities of Escherichia coli strains from a turkey operation. J Am Vet Med Assoc 2002; 221:411–416.
14. van den Bogaard AE, London N, Driessen C, et al. Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother 2001; 47:763–771.
15. Khan SA, Nawaz MS, Khan AA, et al. Transfer of erythromycin resistance from poultry to human clinical strains of Staphylococcus aureus. J Clin Microbiol 2000; 38:1832–1838.
16. Odensvik K, Grave K, Greko C. Antibacterial drugs prescribed for dogs and cats in Sweden and Norway 1990–1998. Acta Vet Scand 2001; 42:189–198.
17. Rantala M, Holso K, Lillas A, et al. Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet Rec 2004; 155:259–262.
18. Weese JS. Investigation of antimicrobial use and the impact of antimicrobial use guidelines in a small animal veterinary teaching hospital: 1995–2004. J Am Vet Med Assoc 2006; 228:553–558.
19. Agresti A, Min Y. Unconditional small-sample confidence intervals for the odds ratio. Biostatistics 2002; 3:379–386.
20. Call DR, Davis MA, Sawant AA. Antimicrobial resistance in beef and dairy cattle production. Anim Health Res Rev 2008; 9:159–167.
21. Prescott JF. Antimicrobial use in food and companion animals. Anim Health Res Rev 2008; 9:127–133.
22. Wegener HC. Antibiotics in animal feed and their role in resistance development. Curr Opin Microbiol 2003; 6:439–445.
23. USDA. Dairy 2007, part IV: reference of dairy cattle health and management practices in the United States, 2007. Fort Collins, Colo: USDA, APHIS, Veterinary Services Centers for Epidemiology and Animal Health, 2009.
24. USDA. Beef 2007–08, part V: reference of beef cow-calf management practices in the United States, 2007–08. Fort Collins, Colo: USDA, APHIS, Veterinary Services Centers for Epidemiology and Animal Health, 2010.
25. USDA. Part IV: changes in the U.S. pork industry, 1990–2006. Fort Collins, Colo: USDA, APHIS, Veterinary Services Centers for Epidemiology and Animal Health, 2008.
26. Wener KM, Schechner V, Gold HS, et al. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother 2010; 54:2010–2016.
27. Doern GV. Antimicrobial use and the emergence of antimicrobial resistance with 1Streptococcus pneumoniae in the United States. Clin Infect Dis 2001; 33:S187–S192.
28. Grønvold A-MR, L'Abée-Lund TM, Sørum H, et al. Changes in fecal microbiota of healthy dogs administered amoxicillin. FEMS Microbiol Ecol 2010; 71:313–326.
29. Shaheen BW, Boothe DM, Oyarzabal OA, et al. Antimicrobial resistance profiles and clonal relatedness of canine and feline Escherichia coli pathogens expressing multidrug resistance in the United States. J Vet Intern Med 2010; 24:323–330.
30. Nam H-M, Lee H-S, Byun J-W, et al. Prevalence of antimicrobial resistance in fecal Escherichia coli isolates from stray pet dogs and hospitalized pet dogs in Korea. Microb Drug Resist 2010; 16:75–79.
31. Pedersen K, Pedersen K, Jensen H, et al. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs. J Antimicrob Chemother 2007; 60:775–781.
32. Jackson CR, Fedorka-Cray PJ, Davis JA, et al. Prevalence, species distribution and antimicrobial resistance of enterococci isolated from dogs and cats in the United States. J Appl Microbiol 2009; 107:1269–1278.
33. Ruscher C, Lübke-Becker A, Wleklinski C-G, et al. Prevalence of methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet Microbiol 2009; 136:197–201.
34. Abbott Y, Leggett B, Rossney AS, et al. Isolation rates of methicillin-resistant Staphylococcus aureus in dogs, cats and horses in Ireland. Vet Rec 2010; 166:451–455.
35. Faires M, Traverse M, Tater K, et al. Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs. Emerg Infect Dis 2010; 16:69–75.
36. Manian F. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 2003; 36:26–28.
37. Weese J, Caldwell F, Willey B, et al. An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital. Vet Microbiol 2006; 114:160–164.
38. Weese JS, Faires M, Rousseau J, et al. Cluster of methicillin-resistant Staphylococcus aureus colonization in a small animal intensive care unit. J Am Vet Med Assoc 2007; 231:1361–1364.
39. AVMA website. Guidelines for veterinary prescription drugs, 2010. Available at: www.avma.org/issues/policy/prescription_drugs.asp.Accessed Jan 27, 2011.
40. Berge ACB, Moore DA, Sischo WM. Field trial evaluating the influence of prophylactic and therapeutic antimicrobial administration on antimicrobial resistance of fecal Escherichia coli in dairy calves. Appl Environ Microbiol 2006; 72:3872–3878.
41. Vieira AR, Houe H, Wegener HC, et al. Association between tetracycline consumption and tetracycline resistance in Escherichia coli from healthy Danish slaughter pigs. Foodborne Pathog Dis 2009; 6:99–109.
Advertisement
Objective—To determine frequency of antimicrobial drug (AMD) use in dogs within 12 months prior to admission to a veterinary teaching hospital.
Design—Owner survey and medical records review.
Animals—435 dogs admitted to a veterinary teaching hospital.
Procedures—Demographic characteristics and information regarding AMD use in dogs were obtained from medical records and results of surveys completed by owners of dogs.
Results—242 (55.6%) dogs received at least 1 AMD within 12 months prior to hospital admission; 125 (51.7%) of these dogs had a disease of the integument at the time of admission. β-Lactam AMDs were used more frequently than AMDs of any other class (176/242 [72.7%] dogs). Three hundred sixty-eight dogs had a medical problem at the time of hospital admission; 225 (61.1%) of these dogs had received at least 1 AMD within 12 months prior to hospital admission. Dogs referred by a veterinarian to the hospital were 2.39 times as likely to have received at least 1 AMD within 30 days prior to hospital admission as were dogs admitted without a referral.
Conclusions and Clinical Relevance—Results indicated AMDs were frequently administered to dogs prior to admission to the teaching hospital. Use of AMDs in animals could be a risk factor for coselection and spread of multidrug-resistant pathogens, and colonization or infection of dogs with such pathogens could have a negative impact on the health of other animals and humans.
The authors thank Dr. Rocio Nava-Hoet, Christina Jackson, and Amber Reed for assistance with survey development and data collection.